Serum Life Sciences

Serum Life Sciences, a subsidiary of Serum Institute of India, is dedicated to advancing global health by investing in innovative biotechnology and healthcare companies. The firm has made significant investments in various sectors, including biotechnology, pharmaceuticals, agriculture, and sustainability.

The company's investment strategy encompasses early to late-stage funding, targeting both domestic and international markets. Notable investments include a $10 million commitment to GreenLight Biosciences, a Boston-based RNA-focused biotech company, and a £50 million investment in Oxford Biomedica, a UK-based gene and cell therapy group. These investments aim to accelerate the development and distribution of life-saving vaccines and therapies.

Through these strategic partnerships, Serum Life Sciences seeks to enhance its portfolio and contribute to the global fight against infectious diseases, leveraging its expertise and resources to support the growth of companies aligned with its mission to improve global health outcomes.